{
  "spec_version": "3",
  "endpoint": "segments",
  "stock_code": "8129",
  "company_name": "東邦ホールディングス",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/8129/financials/",
  "api_url": "/api/8129/segments.json",
  "updated": "2026-08-15",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/8129/financials/",
  "source": {
    "primary": [
      "有価証券報告書（セグメント情報）"
    ],
    "extraction": "EDINET の XBRL から機械抽出",
    "caveat": "セグメント区分は各期の開示区分をそのまま採録しており、期をまたいだ区分の連続性は保証しない"
  },
  "segment": [
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1068320,
      "profit": 8273,
      "assets": 481775
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "情報機器販売事業",
      "sales": 1396,
      "profit": 65,
      "assets": 2107
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "治験施設支援事業",
      "sales": 370,
      "profit": 162,
      "assets": 765
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 92060,
      "profit": 1595,
      "assets": 44332
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1206958,
      "profit": 27315,
      "assets": 534400
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "情報機器販売事業",
      "sales": 1208,
      "profit": -136,
      "assets": 1994
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "治験施設支援事業",
      "sales": 531,
      "profit": 301,
      "assets": 846
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 99776,
      "profit": 2924,
      "assets": 47771
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1133939,
      "profit": 13998,
      "assets": 480592
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "情報機器販売事業",
      "sales": 1327,
      "profit": 81,
      "assets": 2009
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "治験施設支援事業",
      "sales": 322,
      "profit": 74,
      "assets": 817
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 95457,
      "profit": 1244,
      "assets": 44858
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1113903,
      "profit": 17155,
      "assets": 512700
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "情報機器販売事業",
      "sales": 1463,
      "profit": 64,
      "assets": 2053
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "治験施設支援事業",
      "sales": 323,
      "profit": 89,
      "assets": 934
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 97651,
      "profit": 3564,
      "assets": 47214
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1127836,
      "profit": 16084,
      "assets": 510467
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "情報機器販売事業",
      "sales": 1156,
      "profit": 36,
      "assets": 2219
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "治験施設支援事業",
      "sales": 280,
      "profit": 55,
      "assets": 898
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 92926,
      "profit": 1425,
      "assets": 46062
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1166422,
      "profit": 18011,
      "assets": 514304
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "情報機器販売事業",
      "sales": 1133,
      "profit": 29,
      "assets": 2298
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "治験施設支援事業",
      "sales": 256,
      "profit": -126,
      "assets": 674
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 95896,
      "profit": 2700,
      "assets": 51019
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他周辺事業",
      "sales": 704,
      "profit": -681,
      "assets": 2136
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1116229,
      "profit": 3970,
      "assets": 511291
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 2250,
      "profit": 729,
      "assets": 5357
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 91089,
      "profit": 2688,
      "assets": 53169
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他周辺事業",
      "sales": 4329,
      "profit": 395,
      "assets": 5580
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1168155,
      "profit": 9967,
      "assets": 535156
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 1899,
      "profit": 884,
      "assets": 17796
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 91786,
      "profit": 2963,
      "assets": 54230
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他周辺事業",
      "sales": 4985,
      "profit": 621,
      "assets": 5571
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1292688,
      "profit": 13995,
      "assets": 562837
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 2105,
      "profit": 864,
      "assets": 18123
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 92337,
      "profit": 2431,
      "assets": 55845
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他周辺事業",
      "sales": 4701,
      "profit": 448,
      "assets": 5408
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1375794,
      "profit": 19453,
      "assets": 598277
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 2442,
      "profit": 755,
      "assets": 19338
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 93774,
      "profit": 1546,
      "assets": 56763
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "その他周辺事業",
      "sales": 5059,
      "profit": 655,
      "assets": 5863
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品卸売事業",
      "sales": 1415289,
      "profit": 19033,
      "assets": 585328
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品製造販売事業",
      "sales": 2615,
      "profit": 729,
      "assets": 19446
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "調剤薬局事業",
      "sales": 95531,
      "profit": 852,
      "assets": 58691
    }
  ]
}